Sat.Dec 31, 2022 - Fri.Jan 06, 2023

article thumbnail

Study finds hepatitis C cure saved Medicaid $15 billion

PhRMA

New research published in the American Journal of Managed Care (AJMC) underscores the critical role that medicines play in improving health and reducing disease complications and other, often costly, medical care and services. The study finds that since curative direct-acting antiviral medications for hepatitis C were approved in 2013, even after factoring in the cost of treatment, Medicaid has saved an estimated $15 billion in avoided health care costs and nearly 285,000 Medicaid enrollees are

211
211
article thumbnail

To Improve Retail Pharmacy, Look Beyond Figures and Dig Into Facts

Drug Topics

A local West Virginia mechanic exemplifies the kind of problem-solving that pharmacy executives from major chains should apply to their stores.

201
201
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Speech Therapy May Effectively Address Long COVID Communication Issues

Pharmacy Times

In addition to the physical symptoms of long COVID, patients have reported vocal, verbal, and cognitive issues that disrupt their ability to communicate.

article thumbnail

For people with disabilities, reproductive health care comes with deep-rooted barriers

STAT

Pregnancy, for the average person, is an exercise of extremes — swelling body, welling emotions, surging hormones. For people with chronic conditions and other disabilities, the experience can be even more jarring, full of additional barriers, stigma, and risks. But it’s not just pregnancy. In the United States, disabled people are less likely to be taught comprehensive sexual education and given access to contraceptives, and are more likely to have unintended pregnancies.

145
145
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Google and DeepMind share work on medical chatbot Med-PaLM

pharmaphorum

Google and DeepMind have developed an artificial intelligence-powered chatbot tool called Med-PaLM designed to generate “safe and helpful answers” to questions posed by healthcare professionals and patients. The tool is an example of a large language model or LLM, which are designed to understand queries and generate text responses in plain language, drawing from large and complex datasets – in this case, medical research.

137
137
article thumbnail

AMD Risk Not Tied to Long-Term Metformin Use

Drug Topics

The researchers reported that there was no significant difference in the age-related macular degeneration prevalence among the 3 study groups.

201
201

More Trending

article thumbnail

Opinion: NIH advances landmark recommendations on disability inclusion and anti-ableism

STAT

A diverse and inclusive workforce benefits science and research. But unless it includes people living with a disability — the largest minority group in the U.S. and around the world — research will never be fully representative and science will not reach its full potential. Although 27% of U.S. adults live with a disability, only 10% of science, engineering, and health doctorate holders, and less than 2% of researchers funded by the National Institutes of Health, report having a di

138
138
article thumbnail

Cell therapies might revolutionise treatment for multiple sclerosis patients

Pharmaceutical Technology

While the treatment options for multiple sclerosis (MS) patients are growing each year with the approval of new agents, all of the currently marketed treatments only slow the disease’s progression and sometimes carry risks of severe side effects, such as liver failure or the development of viral infections. However, new mechanisms of action (MoAs) are in constant development, with some of the more innovative ones utilizing cell-based therapies.

115
115
article thumbnail

How to Prioritize Tamiflu in Cases of Shortages

Drug Topics

Reports of localized supply issues with Tamiflu have left some providers wondering how to best prioritize who gets the antiviral during a rough flu season.

187
187
article thumbnail

Researchers Discover New Immune Target for Heart Disease Treatment

Pharmacy Times

The protein, called suPAR, has long been known to be a biomarker for poor outcomes and disease progression in both kidney disease and cardiovascular disease.

article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

STAT+: The health tech tracker for 2023’s first quarter: 12 industry events to watch

STAT

Continuing economic uncertainty and the threat of a recession are casting a pall over health tech in 2023 — a dramatic shift for an industry that enjoyed abundant funding in the pandemic’s early stages. Last quarter’s string of layoffs at companies like Ro, Noom and ThirtyMadison portend tight budgets and conservative contracts this year, with employers unsure about which digital offerings actually drive down health care costs for workers.

FDA 128
article thumbnail

Carbon Health announces another round of layoffs, corporate restructuring amid challenging market conditions

Fierce Healthcare

Carbon Health announces another round of layoffs, corporate restructuring amid challenging market conditions. hlandi. Fri, 01/06/2023 - 20:01.

129
129
article thumbnail

Drug Price Hikes Already Found in 2023

Drug Topics

List prices of 450 medications have increased 5% overall at the beginning of 2023. More price hikes are expected.

212
212
article thumbnail

Study: Common Fatty Acid Contributes to Pain, Temperature Sensitivity in Psoriasis Plaques

Pharmacy Times

Results show an association between linoleic acid, found in nuts, seeds, and vegetable oils, and increased hypersensitivity in psoriatic lesions.

139
139
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

STAT+: Fate Therapeutics plans mass layoffs, after early end to cell therapy deal with Janssen

STAT

SAN DIEGO — Fate Therapeutics, a biotech upstart with big ambitions to use cell-based therapies to treat autoimmune diseases and cancer, is now planning to cut back on both jobs and experimental drugs after an early end to a deal with Janssen. The setback, announced Thursday, will cut the company’s size to 220 workers by the end of the first quarter of this year.

article thumbnail

Forks in the road lead one medical expert to a ‘game changing’ liver treatment

PharmaVoice

Durect’s chief medical officer altered his retirement plans to take a leading role at the company, which is developing a treatment for severe alcohol-associated hepatitis.

111
111
article thumbnail

Highlights: What Pharmacists Need to Know about ACIP’s Latest 2023 Vaccination Schedule Updates

Drug Topics

Keep your pharmacy services up to date with the latest 2023 ACIP vaccination schedule updates and recommendations.

Vaccines 200
article thumbnail

Physical Activity 3 Times Per Week May Reduce Symptoms of Depression in Children and Adolescents

Pharmacy Times

The benefits of physical activity may be greater for children and adolescents with clinical depression or depressive symptoms, who may develop anxiety and other disorders in adulthood.

138
138
article thumbnail

Walgreens to pursue certification to provide abortion pills in pharmacies

STAT

Walgreens plans to seek certification to begin providing abortion pills under new Food and Drug Administration rules that allow the drugs to be distributed by retail pharmacies, the company told STAT on Wednesday.  “We are working through the registration, necessary training of our pharmacists, as well as evaluating our pharmacy network in terms of where we normally dispense products that have extra FDA requirements and will dispense these consistent with federal and state laws,

FDA 112
article thumbnail

Teladoc unveils new app integrating services for primary care and mental health, expands Spanish language offerings

Fierce Healthcare

Teladoc unveils new app integrating services for primary care and mental health, expands Spanish language offerings. hlandi. Thu, 01/05/2023 - 16:07.

124
124
article thumbnail

Teen Drug Overdose Deaths on the Rise

Drug Topics

The CDC has reported an increase in drug overdose deaths from 2019 to 2022 in adolescents aged 10 to 19 years.

201
201
article thumbnail

Cancer Vaccine Found Efficacious, Safe in Killing, Preventing Brain Cancer

Pharmacy Times

The dual-action cell therapy is designed to eliminate established tumors, train the immune system to eradicate a primary tumor, and prevent recurrence.

article thumbnail

UK partners with BioNTech on clinical trials of mRNA cancer therapies

pharmaphorum

The UK has formed an partnership with German biotech BioNTech to provide up to 10,000 patients with access to personalised cancer therapies, in another example of the country embracing the mRNA technologies that underpinned COVID-19 vaccines. The cancer immunotherapies will mainly be provided in the context of clinical trials over the alliance, which extends out to 2030, but also covers supply of commercial therapies if approved in the interim.

Vaccines 110
article thumbnail

Commonwealth Fund: Medicare inpatient spending concentrated among 2 systems in most regions

Fierce Healthcare

Commonwealth Fund: Medicare inpatient spending concentrated among 2 systems in most regions. rking. Thu, 01/05/2023 - 15:07.

129
129
article thumbnail

Flu Shot Reduced Outpatient Care Needed in 2021-2022 Flu Season

Drug Topics

Research on last season’s influenza vaccine efficacy bodes well for patients who have gotten their flu shot this season.

Vaccines 187
article thumbnail

Overcoming the Biotech Investment Paradox

Pharmacy Times

Big pharma companies have become more measured in their risk taking, with mergers and acquisitions gradually giving way to joint ventures and partnerships.

132
132
article thumbnail

6 research and development life sciences predictions for 2023

pharmaphorum

From enabling patient choice during clinical trials to strengthening vital partnerships across the quality ecosystem, connected data will become the lifeblood that enables life sciences teams to collaborate efficiently and effectively in 2023. Veeva’s industry experts share their predictions about how breaking down silos across clinical, regulatory, safety, and quality teams will benefit patients.

FDA 109
article thumbnail

How mental health made the 'remarkable transition' to virtual: study

Fierce Healthcare

How mental health made the 'remarkable transition' to virtual: study. fdiamond. Thu, 01/05/2023 - 15:21.

139
139
article thumbnail

Psoriasis Can Be More Challenging in the Winter

Drug Topics

Patients with psoriasis seem to suffer more in the wintertime when flare-ups are much more common.

201
201
article thumbnail

Improved Access to Direct-acting Antivirals Lowers Hepatitis C Incidence Rates

Pharmacy Times

Study finds a strong decline in hepatitis C incidence in the years immediately following broad access to direct-acting antiviral drugs.

149
149
article thumbnail

What is a dangerous level of blood sugar?

The Checkup by Singlecare

If you have Type 1 or Type 2 diabetes , your healthcare provider will recommend that you aim to stay within your target range, or normal range, as much as possible. Doing so is best for your overall health and helps you prevent or delay long-term complications of high blood sugar. . Hypoglycemia is the medical term for low blood glucose levels (or blood sugar levels).

Hospitals 105
article thumbnail

Newron says pivotal treatment-resistant schizophrenia trial is a go

pharmaphorum

Encouraged by new data, Newron Pharmaceuticals has said it will start a registration study of would-be blockbuster evenamide in treatment-resistant schizophrenia (TRS) later this year. The Italian biopharma said it had decided to press ahead with the new study after assessing results from 100 patients with TRS in open-label studies who received the glutamate modulator drug as an add-on to their current therapy for more than six months.

Labelling 105
article thumbnail

FDA Allows Dispensing of Mifepristone in Retail Pharmacies

Drug Topics

Following certification, brick-and-mortar pharmacies will be able to provide the medication to patients.

FDA 187
article thumbnail

FDA Grants Breakthrough Therapy Designation to Adagrasib, Cetuximab Combination

Pharmacy Times

The findings show promising clinical activity and a favorable tolerability profile in the treatment of KRASG12C-mutated advanced colorectal cancer.

FDA 123